There are lots of ways to invest in bonds. Exchange-traded funds (ETFs) are the simplest way to add some bond exposure to a ...
The company continues to focus on enterprise customers, where it is seeing the strongest growth. The number of customers with ...
Solana combines growth potential with a proven track record, which is unusual for an altcoin. Solana's speed made it famous, ...
For years, Tesla also benefited from a powerful advantage: scarcity. Investors who believed in Musk's ability to build ...
For a bit, the S&P 500 Dow Jones Indices -- which manages the S&P 500 -- was considering altering its rules to fast-track ...
On June 1, mission-critical public safety juggernaut Motorola Solutions (MSI 0.09%) acquired counter-drone technology ...
A handful of megacaps have closed enough ground to make the AI chip leader's crown look less than permanent -- but each would ...
Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.
The pharmaceutical outfit has taken a savvy step forward. Now it just needs to repeat the process a few more times.
It's not often that a major tech stock can be declared a "once-in-a-decade" opportunity, but that's what Microsoft ( MSFT ...
Had it happened just a few months earlier -- when the hype surrounding the company was stronger -- Uber might have fared ...
In its fiscal first quarter, Astera Labs saw revenue jump 93.5% to $308.4 million, with adjusted (non-GAAP) earnings jumping ...
Investors are clearly worried about the safety of Pfizer's dividend, which is reasonable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results